Company Filing History:
Years Active: 2022
Title: Mudita Pincha: Innovator in Bispecific Antigen Binding Molecules
Introduction
Mudita Pincha is a notable inventor based in Schlieren, Switzerland. He has made significant contributions to the field of biotechnology, particularly in the development of bispecific antigen binding molecules. His innovative work has the potential to impact therapeutic approaches in various medical conditions.
Latest Patents
Mudita Pincha holds a patent for a bispecific antigen binding molecule designed for a costimulatory TNF receptor. This invention relates to novel bispecific antigen binding molecules that comprise at least one moiety capable of specific binding to OX40 and at least one moiety capable of specific binding to tenascin C (TnC). The patent outlines methods for producing these molecules and their applications in medical treatments.
Career Highlights
Mudita Pincha is currently employed at Hoffmann-La Roche Inc., a leading company in the pharmaceutical and biotechnology sectors. His work at the company has allowed him to collaborate with other talented professionals in the field, enhancing the development of innovative therapeutic solutions.
Collaborations
Some of Mudita Pincha's coworkers include Maria Amann and Sandra Grau-Richards. Their collaborative efforts contribute to the advancement of research and development in their respective areas of expertise.
Conclusion
Mudita Pincha's contributions to the field of bispecific antigen binding molecules exemplify the innovative spirit of modern biotechnology. His work not only showcases his expertise but also highlights the importance of collaboration in driving scientific advancements.